Viewray (NASDAQ:VRAY) issued its quarterly earnings results on Thursday. The company reported ($0.17) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.23) by $0.06, Briefing.com reports. The business had revenue of $20.66 million for the quarter, compared to the consensus estimate of $20.38 million. Viewray had a negative net margin of 105.09% and a negative return on equity of 105.63%. The firm’s quarterly revenue was up 3.7% on a year-over-year basis. During the same quarter in the prior year, the company earned ($0.38) EPS. Viewray updated its FY 2019 guidance to EPS.
NASDAQ:VRAY traded down $0.19 on Friday, hitting $8.15. 1,355,132 shares of the stock were exchanged, compared to its average volume of 1,252,275. The stock has a market capitalization of $798.39 million, a P/E ratio of -7.84 and a beta of 1.30. Viewray has a 52 week low of $4.86 and a 52 week high of $13.21. The company has a current ratio of 6.47, a quick ratio of 5.56 and a debt-to-equity ratio of 0.25.
A number of large investors have recently made changes to their positions in VRAY. Bank of America Corp DE raised its holdings in Viewray by 209.7% during the 2nd quarter. Bank of America Corp DE now owns 14,710 shares of the company’s stock worth $101,000 after purchasing an additional 9,960 shares during the last quarter. Northern Trust Corp increased its stake in shares of Viewray by 61.1% in the 2nd quarter. Northern Trust Corp now owns 545,384 shares of the company’s stock valued at $3,775,000 after acquiring an additional 206,783 shares during the last quarter. Russell Investments Group Ltd. increased its stake in shares of Viewray by 46.7% in the 3rd quarter. Russell Investments Group Ltd. now owns 605,262 shares of the company’s stock valued at $5,671,000 after acquiring an additional 192,637 shares during the last quarter. Wells Fargo & Company MN increased its stake in shares of Viewray by 46.0% in the 3rd quarter. Wells Fargo & Company MN now owns 141,048 shares of the company’s stock valued at $1,320,000 after acquiring an additional 44,415 shares during the last quarter. Finally, JPMorgan Chase & Co. increased its stake in shares of Viewray by 5,511.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 564,294 shares of the company’s stock valued at $5,282,000 after acquiring an additional 554,237 shares during the last quarter.
TRADEMARK VIOLATION NOTICE: This news story was originally published by Ticker Report and is the sole property of of Ticker Report. If you are reading this news story on another site, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright legislation. The legal version of this news story can be accessed at https://www.tickerreport.com/banking-finance/4223606/viewray-vray-issues-quarterly-earnings-results-beats-estimates-by-0-06-eps.html.
Viewray Company Profile
ViewRay, Inc designs, manufactures and markets MRIdian, the magnetic resonance imaging (MRI)-guided radiation therapy system to image and treat cancer patients simultaneously. The Company offers radiation therapy technology combined with magnetic resonance imaging. MRIdian integrates MRI technology, radiation delivery and the Company’s software to locate, target and track the position and shape of soft-tissue tumors while radiation is delivered.
Featured Article: How to Track your Portfolio in Google Finance
Receive News & Ratings for Viewray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viewray and related companies with MarketBeat.com's FREE daily email newsletter.